ETFIQData as of Nov 19, 2026. · etfiq.com/funds/qqqs

QQQS Fact Sheet: Invesco NASDAQ Future Gen 200 ETF

Share
$33.28
close, Nov 20, 2026

Over the year to Nov 19, 2026, QQQS returned +11.7% in total and charged 0.20% a year.

1-year total return
+9.0%
to Nov 20, 2026
Expense ratio
0.20%
a year
Net assets
$19m
on Nov 19, 2026
Net flow, last 5 trading days
$0
daily basis to Nov 19, 2026

Growth of $10,000, 1 year

QQQS $11,170 +11.7% · Total return, distributions reinvested, Nov 19, 2025 to Nov 19, 2026.

Returns

WindowTotal return
1 month−15.9%
3 months−26.1%
Year to date−2.1%
1 year+9.0%
3 years+58.9%

Total return, distributions reinvested, each window to Nov 20, 2026.

Ten largest positions

HoldingWeight
TTEC Holdings Inc1.35%
Myriad Genetics Inc1.11%
Azenta Inc0.93%
OrthoPediatrics Corp0.90%
Arq Inc0.89%
OneSpan Inc0.89%
QTREX Quantum Ltd0.87%
Inovio Pharmaceuticals Inc0.87%
Pacific Biosciences of California Inc0.84%
SI-BONE Inc0.80%

QQQS top ten by weight, 9.4% of the fund, of its 203 equity positions, from the holdings published by its issuer for Nov 19, 2026.

Facts

Equity fund · Tracks the Nasdaq Innovators Completion Cap Index · First traded Oct 13, 2022 · Benchmark Its own holdings, as of Nov 19, 2026

Source: ETFIQ, from issuer disclosures, SEC filings and exchange prices. Returns from daily closes, distributions reinvested; each number is dated beside it, and every one is on the fund’s page.Cite as: ETFIQ, QQQS Fact Sheet: Invesco NASDAQ Future Gen 200 ETF. Data as of Nov 19, 2026. https://etfiq.com/funds/qqqs/fact-sheet/ETFIQ is an independent publisher. Not an issuer, broker or adviser. No recommendations. Printed from etfiq.com/funds/qqqs.